drug
sumatriptan
Marketedupdated 3mo agoby Florida Pharmaceutical Products LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval156 co-mentions · 78 sources
- drugIMITREX127 co-mentions · 73 sources
- drugIMITREX STATDOSE88 co-mentions · 57 sources
- drugZembrace Symtouch57 co-mentions · 57 sources
- drugSUMATRIPTAN SUCCINATE57 co-mentions · 57 sources
- tagSmall Molecule28 co-mentions · 28 sources
- drugNAPROXEN SODIUM10 co-mentions · 5 sources
- drugNaprogesic10 co-mentions · 5 sources
all catalysts(0)
nothing on the calendar yet
Trials studying sumatriptan
- phase4Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
- —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- phase1Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates
- phase3A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
- phase3Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 16, 2030
~3.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (9)
- Jul 19, 2031formulationUS 92112824.9y
- Jun 16, 2030formulationUS 106033053.8y
- Jun 16, 2030formulationUS 113379623.8y
- Jun 16, 2030formulationUS 120901393.8y
- Jun 16, 2030formulationUS 96102803.8y
- Jun 16, 2030formulationUS 99747703.8y
- May 9, 2026formulationUS 8268791
- May 9, 2026formulationUS 8440631
- May 9, 2026formulationUS 9283280
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that